Jointechlabs Secures CE Mark Approval for Mini-Stem System in Europe, Will Soon Launch Regenerative Medicine Product
Mini-Stem System has received CE Mark approval
Read moreMini-Stem System has received CE Mark approval
Read moreExcerpts from a presentation by Dr. Nathan Katz, CEO of Jointechlabs, to The Orthobiologic Insititute, on August 14, 2024.
Read moreOrthopedic surgery presents hope – and risks. There are alternatives, including microfat, that should be considered.
Read moreDr. Mitchell Sheinkop discusses Jointechlabs’ recent presentation of scientific papers at orthobiologic conferences in Europe.
Read moreChicken soup was and is a popular cure-all. Today, joint preservation with orthobiologics such as microfragmented adipose tissue for grades 2-3 osteoarthritis is an emerging standard of care.
Read moreThe rising global market for regenerative medicine not only offers hope in the form of advanced therapies but also presents a fertile ground for robust investment returns.
Read moreRenowned doctors Dr. William D. Murrell (orthopedics) and Dr. Carlos Mercado (aesthetics) bring new scientific and market savvy to the company.
Read moreBMAC and microfat both provide orthopedic advantages. Microfat can also be used when BMAC is not indicated.
Read more“Join us on the Talk is Biotech! podcast as we chat with Nathan Katz about his incredible journey from completing his PhD to becoming a medical scientist and ultimately a successful CEO of Jointechlabs, Inc.”
Read moreJointechlabs has been granted a core Chinese patent and has entered into a joint venture to develop the microfat market in China.
Read more